Key player · Company profile
Bristol-Myers Squibb Company
Named as a key player in 231 of our reports, across 33 regions and countries.
Named as a key player in 231 of our reports, across 33 regions and countries.
2023–2033 CAGR · estimates
Australia 7
Brazil 7
Canada 7
China 7
Ecuador 7
Egypt 7
France 7
Germany 7
Hong Kong 7
India 7
Italy 7
Japan 7
Kenya 7
Malaysia 7
Mexico 7
New Zealand 7
Philippines 7
Russia 7
Saudi Arabia 7
Singapore 7
South Africa 7
Spain 7
Thailand 7
UAE 7
UK 7
US 7| Market | Category | World 2023 | CAGR |
|---|---|---|---|
| Anti-Depressants Drugs | Pharmaceuticals | $18 Bn | 2.7% |
| Over The Counter (OTC) Medications for Cough, Cold & Flu Drugs | OTC & Nutraceuticals | $14.5 Bn | 4.1% |
| Atopic Dermatitis Drugs | Pharmaceuticals | $11.2 Bn | 12.2% |
| Alexipharmic Drugs | Pharmaceuticals | – | – |
| Anticoagulants | Pharmaceuticals | – | – |
| Antithrombotic Drugs | Pharmaceuticals | – | – |
| Atherosclerosis Drugs | Pharmaceuticals | – | – |
Named as key players in the same markets as Bristol-Myers Squibb Company (number of shared markets).
Sanofi7 shared markets
AstraZeneca5 shared markets
Johnson & Johnson4 shared markets
Novartis AG3 shared markets
Pfizer Inc.3 shared markets
AbbVie Inc.2 shared markets
Amgen Inc.2 shared markets
Bayer AG2 shared markets
Search all reports for Bristol-Myers Squibb Company All companies